Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-16,062
Closed -$1.17M 55
2018
Q4
$1.17M Sell
16,062
-2,392
-13% -$169K 2.54% 3
2018
Q3
$1.25M Sell
18,454
-1,696
-8% -$108K 2.13% 7
2018
Q2
$1.17M Sell
20,150
-794
-4% -$44.8K 1.99% 8
2018
Q1
$1.09M Buy
20,944
+15,572
+290% +$841K 1.93% 7
2017
Q4
$288K Sell
5,372
-2,243
-29% -$124K 0.48% 94
2017
Q3
$465K Buy
7,615
+1,717
+29% +$104K 0.81% 54
2017
Q2
$361K Hold
5,898
0.67% 74
2017
Q1
$358K Sell
5,898
-210
-3% -$12.7K 0.65% 73
2016
Q4
$343K Buy
6,108
+105
+2% +$6.14K 0.65% 79
2016
Q3
$357K Sell
6,003
-961
-14% -$56.2K 0.7% 71
2016
Q2
$328K Buy
6,964
+1,245
+22% +$66.3K 0.61% 67
2016
Q1
$289K Sell
5,719
-363
-6% -$17.8K 0.51% 84
2015
Q4
$307K Sell
6,082
-882
-13% -$44.5K 0.55% 78
2015
Q3
$328K Sell
6,964
-966
-12% -$51.3K 0.6% 70
2015
Q2
$430K Buy
7,930
+1,813
+30% +$102K 0.58% 65
2015
Q1
$335K Sell
6,117
-1,161
-16% -$65.7K 0.47% 86
2014
Q4
$395K Sell
7,278
-325
-4% -$18.1K 0.43% 89
2014
Q3
$430K Sell
7,603
-855
-10% -$48K 0.5% 77
2014
Q2
$467K Sell
8,458
-6,325
-43% -$345K 0.56% 65
2014
Q1
$801K Sell
14,783
-3,068
-17% -$159K 0.83% 26
2013
Q4
$852K Sell
17,851
-1,748
-9% -$79.9K 0.86% 32
2013
Q3
$891K Sell
19,599
-9
-0% -$411 0.9% 28
2013
Q2
$869K Buy
+19,608
New +$876K 0.89% 34

Other funds holding MRK

Banced Corp's MRK Position: Q1 2019 in Review

Banced Corp sold out of Merck (MRK) in Q1 2019, closing a stake of 16,062 shares — an estimated $1.17M sold.

Banced Corp first reported a position in MRK in Q2 2013 and held it in 23 quarters. The position peaked at $1.25M in Q3 2018. 2,292 funds tracked by Wall St. Rank hold MRK as of Q1 2019.

  • Banced Corp reported no remaining Merck position as of Q1 2019 after selling out during the quarter.
  • Banced Corp sold 16,062 Merck shares in Q1 2019, an estimated $1.17M.
  • Banced Corp first reported a position in Merck in Q2 2013 and held it in 23 quarters.
  • Banced Corp's Merck position peaked at $1.25M in Q3 2018.
  • 2,292 funds tracked by Wall St. Rank held Merck as of Q1 2019.

Based on Banced Corp's 13F filing for Q1 2019.